Desmin-free cardiomyocytes and myocardial dysfunction in end stage heart failure

S Di Somma1, M P Di Benedetto, G Salvatore

  • 1Medical Department, II Medical School University La Sapienza, Sant' Andrea Hospital, Rome, Italy. sdisomma@unina.it

Insights

Patients with end-stage heart failure from ischemic cardiomyopathy have reduced desmin in heart muscle cells. This desmin deficiency is linked to poorer cardiac function, impacting ejection fraction and pressure.

Area of Science:

  • Cardiology
  • Cell Biology
  • Biochemistry

Background:

  • Desmin is a crucial cytoskeletal protein in cardiomyocytes.
  • Alterations in desmin may contribute to heart failure pathogenesis.
  • Ischemic cardiomyopathy (ICM) leads to end-stage heart failure.

Purpose of the Study:

  • To quantify desmin levels in myocardial tissue of ICM patients.
  • To investigate the association between desmin content and cardiac function in ICM.
  • To compare desmin expression in ICM hearts versus controls.

Main Methods:

  • Analysis of 18 explanted hearts from ICM patients and control tissues.
  • Light and confocal immunochemistry for desmin localization and quantification.
  • Real-time PCR to measure desmin mRNA levels.
  • Echocardiography and right heart catheterization for cardiac function assessment.

Main Results:

  • Significantly lower desmin-positive myocytes observed in ICM hearts compared to controls (P<0.01).
  • Reduced desmin content confirmed by real-time PCR in ICM patients (P<0.01).
  • Negative correlation between desmin-negative cardiomyocytes and ejection fraction (r=-0.834, P<0.02).
  • Negative relationship between desmin-negative myocytes and capillary wedge pressure (r=-0.688).

Conclusions:

  • End-stage heart failure in ICM is associated with a decreased number of desmin-positive myocytes.
  • Deficiency in cytoskeletal desmin correlates with impaired cardiac function.
  • Desmin may play a significant role in the pathophysiology of ischemic heart failure.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...